Caphosol, a therapeutic option in case of cancer therapy-induced oral mucositis in children?: Results from a prospective multicenter double blind randomized controlled trial

Supportive Care in Cancer

Volumn 22, Issue 1, 2014, Pages 3-6

  Raphael, M F ^a   Den Boer, A M ^a   Kollen, W J W ^b   Mekelenkamp, H ^b   Abbink, F C H ^c   Kaspers, G J L ^c   Zomer Kooijker, K ^a   Molmans, B H W ^d   Tissing, W J E ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTINEOPLASTIC AGENT; CAPHOSOL; MORPHINE; MOUTHWASH; PLACEBO; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; CANCER CHEMOTHERAPY; CANCER THERAPY; CHILD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LETTER; MALE; MOUTH PAIN; MULTICENTER STUDY; ORAL MUCOSITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SOLID TUMOR;

EID: 84890565757     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-2015-0     Document Type: Letter

References (19)

1. Cheng KKF, Lee V, Li CH et al (2011) Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy. Oral Oncol 47:153-162
2. Otmani N, Alami F, Hessissen L et al (2011) Determinants of severe oral mucositis in paediatric cancer patients: a prospective study. Int J Paediatr Dent 21(3):210-216
3. Allen G, Logan R, Gue S (2010) Oral manifestations of cancer treatment in children: a review of the literature. Clin J Oncol Nurs 14(4):481-490
4. Sonis ST, Elting LS, Keefe D et al (2004) Perspectives on cancer therapy-induced mucosal injury. pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9 Suppl):1995-2025
5. Singh M, Papas A (2009) Long-term clinical observation of dental caries in salivary hypofunction patients using a supersaturated calcium-phosphate remineralizing rinse. J Clin Dent 20(3):87-92
6. Papas AS, Clark RE, Martuscelli G et al (2003) A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 31(8):705-712
7. Cancer Therapy Evaluation Program (2006) Common terminology criteria for adverse events, version 3.0. Aug 9, 2006. http://ctep.cancer.gov/ protocolDevelopment/electronic-applications/docs/ctcaev3.pdf. Accessed 19 May 2012
8. Wong DL, Baker CM (1988) Pain in children: comparison of assessment scales. Pediatr Nurs 14(1):9-17
9. Clarkson JE, Worthington HV, Furness S et al (2010) Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev Issue 8. doi: 10.1002/14651858.CD001973.pub4
10. Worthington HV, Clarkson JE, Bryan G et al (2011) Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Review, Issue 4. doi: 10.1002/14651858.CD000978.pub5
11. Wako-Grabowska A, Rzepecki P, Oborska S et al (2011) Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience. Transplant Proc 43(8):3111-3113
12. Hawcutt D, Awoghemi O, Bell E et al (2010) Mucositis prevention: efficacy of supersaturated calcium and phosphate solution in high risk paediatric oncology patients. Pediatr Blood Cancer 55(5):PR025
13. Miyamoto C, Wobb J, Micaily B et al (2009) A retrospective match controlled study of supersaturated calcium phosphate oral rinse (Scpor) vs. supportive care for radiation induced oral mucositis (Om). [Abstract] (no. 10-087). Presented at the 2009 international MASCC/ISOO symposium; June 25-27, 2009; Rome, Italy. In: Support Care Cancer 17:911
14. Bechtel T, Devine S, James AG (2009) Use of a calcium/phosphate oral rinse (Caphosol) to lessen the mucositis following an autologous peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 15(2 Suppl):154
15. Haas ML, Mercedes T, Manyak J et al (2008) Reduction of painful oral mucositis by supersaturated calcium phosphate oral rinse in head and neck cancer patients receiving chemotherapy and radiation. [Poster] (no. 2530). Presented at the 50th congress of the American Society of Therapeutic Radiology and Oncology 2008 (ASTRO); Sep 21-25, 2008; Boston, USA. http://astro2008. abstractsnet.com/acover.wcs?entryid=500686. Accessed 8 Feb 2012
16. Mourao E, Correira A, Pires R (2010) Finally something good. [Abstract]. Presented at the 36th annual meeting of the European Group for Blood and Marrow Transplantation (EBMT); Mar 21-24, 2010; Vienna, Austria. In: Bone Marrow Transplantation (Suppl. 2) 45:S369
17. Nicolatou-Galitis O, Sarri T, Kouloulias V et al (2010) Efficacy and safety of Caphosol on oral mucositis in head and neck cancer patients who received radiotherapy with or without chemotherapy. A pilot study. [Abstract] (no. 08-070). Presented at the 2010 international MASCC/ISOO symposium; June 24-26, 2010; Vancouver, Canada. In: Support Care Cancer 18:S111-S112
18. Skorobogatova EV, Dyshlevaia ZM, Karachunsky AI et al (2011) First Russian experience of calcium phosphate mouth rinse usage for treatment of children with oral mucositis undergoing haematopoietic stem cell transplantation. Bone Marrow Transplant 46(Suppl 1):S192-S193
19. Lazic J, Janic D, Dokmanovic L et al (2011) Incidence of oral mucositis and efficient therapy with supersaturated calcium and phosphate solution in pediatric cancer patients. [Poster]. Presented at the 43rd congress of the International Society of Paediatric Oncology; Oct 26-30, 2011; Auckland, New Zealand. In: Ped Blood Canc 57(5):835